Prediction of various insulin resistance indices for the risk of hypertension among military young adults: the CHIEF cohort study, 2014–2020

Table 1 Baseline characteristics of study cohort

	N = 2,448
Stage I hypertension	795 (32.5)
Isolated systolic hypertension, %	317 (12.9)
Isolated diastolic hypertension, %	346 (14.1)
Combined hypertension, %	132 (5.4)
Stage II hypertension	125 (5.1)
Isolated systolic hypertension, %	33 (1.3)
Isolated diastolic hypertension, %	71 (2.9)
Combined hypertension, %	21 (0.9)
Insulin resistance index
TyG index	8.31 ± 0.55
TG/HDL-C	2.30 ± 2.03
METS-IR	2.01 ± 0.22
ZJU index	125.56 ± 15.54
Age, years	28.15 ± 5.66
Male sex, %	2155 (88.0)
Lifestyle behaviors
Alcohol intake, %	961 (39.3)
Tobacco smoking, %	867 (35.4)
PA levels, %
<150 min/wk	556 (22.7)
150–299 min/wk	931 (38.0)
≥300 min/wk	961 (39.9)
Family history of early onset CVD or hypertension, %	71 (2.9)
Systolic BP, mmHg	112.09 ± 10.31
Diastolic BP, mmHg	66.50 ± 7.08
Waist circumference, cm	81.48 ± 8.30
Body mass index, kg/m²	24.27 ± 3.09
18.5–24.9 kg/m²	1493 (61.0)
25.0–29.9 kg/m²	872 (35.6)
≥30.0 kg/m²	83 (3.4)
Blood test
Total cholesterol, mg/dL	171.94 ± 33.05
LDL-C, mg/dL	103.57 ± 29.10
HDL-C, mg/dL	49.06 ± 10.31
TG, mg/dL	102.56 ± 69.90
FG, mg/dL	92.68 ± 12.76
Impaired fasting glucose, %	309 (12.6)
SUA, mg/dL	6.43 ± 1.37
BUN, mg/dL	12.61 ± 2.87
eGFR, mL/min/1.73m²	107.44 ± 12.82

Continuous variables are expressed as mean ± SD (standard deviation), and categorical variables as N (%)
Impaired fasting glucose is defined as fasting glucose of 100–125 mg/dL
Abbreviations: TyG, triglyceride glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; METS-IR, metabolic score for insulin resistance; ZJU, Zhejiang University; PA, physical activity; BP, blood pressure; LDL-C, low-density lipoprotein cholesterol; FG, fasting plasma glucose; SUA, serum uric acid; BUN, blood urea nitrogen; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate

ISSN: 1475-2840